Dyronib 50 mg Tablet
  1. Home
  2. Pharma Products
  3. Hetero Healthcare Ltd
  4. Dyronib 50 mg Tablet

Dyronib 50 mg Tablet

Dyronib 50 mg Tablet contains dasatinib 50 mg and is an oral targeted anticancer medicine used to treat certain blood cancers. It is used for conditions such as chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. The tablet is a prescription medicine and should be taken under the supervision of an oncologist.

BUY NOW

Category

Dasatinib belongs to the tyrosine kinase inhibitor class and works by blocking abnormal proteins involved in the growth of leukemia cells. It primarily targets BCR-ABL and other kinases that contribute to the development and progression of certain leukemias. Regular blood tests and clinical monitoring may be required because treatment can affect blood-cell counts and may cause fluid retention or other adverse effects. The prescribed dose and duration depend on the specific leukemia, treatment response, and the treating physician’s protocol.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 50 mg
Dosage Form Tablet
Pack Size 60 tablets
Route of Administration Oral
Manufacturer/Marketer Hetero Healthcare Ltd.

Product Also Known As

Dyronib 50mg Tablet, Dyronib 50 mg Tablet, Dyronib 50 Tablet, Dasatinib 50mg Tablet, Dasatinib 50 mg Tablet, Dasatinib Oral Tablet, Dasatinib 50mg Anticancer Tablet